Your browser doesn't support javascript.
loading
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.
Blay, Jean-Yves; Chevret, Sylvie; Le Cesne, Axel; Brahmi, Mehdi; Penel, Nicolas; Cousin, Sophie; Bertucci, Francois; Bompas, Emmanuelle; Ryckewaert, Thomas; Soibinet, Pauline; Boudou-Rouquette, Pascaline; Saada Bouzid, Esma; Soulie, Patrick; Valentin, Thibaud; Lotz, Jean-Pierre; Tosi, Diego; Neviere, Zoé; Cancel, Mathilde; Ray-Coquard, Isabelle; Gambotti, Laetitia; Legrand, Frédéric; Lamrani-Ghaouti, Assia; Simon, Clotilde; Even, Caroline; Massard, Christophe.
Afiliación
  • Blay JY; Centre Léon Bérard & Université Claude Bernard Lyon 1, Lyon, France. Electronic address: jean-yves.blay@lyon.unicancer.fr.
  • Chevret S; Service de Biostatistique, Hôpital Saint Louis (AP-HP), Université Paris Cité, Paris, France.
  • Le Cesne A; Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France.
  • Brahmi M; Centre Léon Bérard & Université Claude Bernard Lyon 1, Lyon, France.
  • Penel N; Centre Oscar Lambret, Lille, France.
  • Cousin S; Institut Bergonié, Bordeaux, France.
  • Bertucci F; Institut Paoli Calmettes, Marseille, France.
  • Bompas E; Institut de Cancérologie de l'Ouest, Centre René Gauducheau, Nantes, France.
  • Ryckewaert T; Centre Oscar Lambret, Lille, France.
  • Soibinet P; Centre J Godinot, Reims, France.
  • Boudou-Rouquette P; Hôpital Cochin Saint Vincent de Paul, Paris, France.
  • Saada Bouzid E; Centre Antoine-Lacassagne, Nice, France.
  • Soulie P; Institut de Cancérologie de l'Ouest, Centre Paul Papin, Angers, France.
  • Valentin T; Institut Claudius Regaud, IUCT, Oncopole, Toulouse, France.
  • Lotz JP; Hôpital Tenon, Paris, France.
  • Tosi D; Institut Régional du Cancer de Montpellier, Centre Val d'Aurelle, Montpellier, France.
  • Neviere Z; Centre Francois Baclesse, Caen, France.
  • Cancel M; CHU Bretonneau, Tours, France.
  • Ray-Coquard I; Centre Léon Bérard & Université Claude Bernard Lyon 1, Lyon, France.
  • Gambotti L; Institut National du Cancer, Boulogne, France.
  • Legrand F; Institut National du Cancer, Boulogne, France.
  • Lamrani-Ghaouti A; Unicancer, Paris, France.
  • Simon C; Unicancer, Paris, France.
  • Even C; Gustave Roussy, Cancer Campus, Grand Paris, Villejuif, France.
  • Massard C; Centre Eugene Marquis, Rennes, France.
Lancet Oncol ; 24(8): 892-902, 2023 08.
Article en En | MEDLINE | ID: mdl-37429302
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Tejidos Blandos / Sarcoma de Parte Blanda Alveolar Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de los Tejidos Blandos / Sarcoma de Parte Blanda Alveolar Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adolescent / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article